NanoViricides
NNVC
#10581
Rank
โ‚ฌ27.21 M
Marketcap
1,06ย โ‚ฌ
Share price
-1.68%
Change (1 day)
-12.85%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): -0,39ย โ‚ฌ

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -0,40ย โ‚ฌ. an increase over its 2025 EPS that were of -0,57ย โ‚ฌ.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026-0,37ย โ‚ฌ-34.92%
2025-0,57ย โ‚ฌ-10%
2024-0,64ย โ‚ฌ-5.41%
2023-0,67ย โ‚ฌ5.71%
2022-0,64ย โ‚ฌ-13.58%
2021-0,74ย โ‚ฌ-66.11%
2020-2,18ย โ‚ฌ1.7%
2019-2,14ย โ‚ฌ-10.98%
2018-2,40ย โ‚ฌ-22.35%
2017-3,09ย โ‚ฌ-10.53%
2016-3,46ย โ‚ฌ375%
2015-0,73ย โ‚ฌ-85.19%
2014-4,91ย โ‚ฌ42.11%
2013-3,46ย โ‚ฌ26.67%
2012-2,73ย โ‚ฌ-6.25%
2011-2,91ย โ‚ฌ14.28%
2010-2,55ย โ‚ฌ100%
2009-1,27ย โ‚ฌ-0%
2008-1,27ย โ‚ฌ-33.33%
2007-1,91ย โ‚ฌ-0%
2006-1,91ย โ‚ฌ4445.07%
2005-0,04205ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-2,82ย โ‚ฌ 604.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
0,90ย โ‚ฌ-325.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,11ย โ‚ฌ-1,127.27%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,62ย โ‚ฌ-753.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-1,38ย โ‚ฌ 245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-1,23ย โ‚ฌ 206.82%๐Ÿ‡บ๐Ÿ‡ธ USA